Sandra and Edward Meyer Cancer Center

You are here

News

New horizons for interferon therapy in MPNs

Tuesday, December 15, 2015

Myeloproliferative neoplasm (MPN) expert Richard Silver, M.D., joined Patient Power at the 2015 American Society of Hematology annual meeting to discuss interferon therapy for the treatment of myelofibrosis and polycythemia vera. Dr. Silver explains interferon, how it works, and the potential benefits of small doses of interferon therapy for MPNs.